These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 19751922)

  • 1. Alzheimer's disease drug development and the problem of the blood-brain barrier.
    Pardridge WM
    Alzheimers Dement; 2009 Sep; 5(5):427-32. PubMed ID: 19751922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." Alzheimer's disease drugs: more than one barrier to breach.
    Roher AE; Kokjohn TA
    Alzheimers Dement; 2009 Sep; 5(5):437-8. PubMed ID: 19751925
    [No Abstract]   [Full Text] [Related]  

  • 3. The blood-brain barrier: bottleneck in brain drug development.
    Pardridge WM
    NeuroRx; 2005 Jan; 2(1):3-14. PubMed ID: 15717053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary on "Alzheimer's Disease Drug Development and the Problem of the Blood-Brain Barrier".
    Simpkins JW
    Alzheimers Dement; 2009 Sep; 5(5):433-4. PubMed ID: 19751923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." The blood-brain barrier: a physical and conceptual challenge.
    Hachinski V; Lee TY
    Alzheimers Dement; 2009 Sep; 5(5):435-6. PubMed ID: 19751924
    [No Abstract]   [Full Text] [Related]  

  • 6. Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease.
    Banks WA
    BMC Neurosci; 2008 Dec; 9 Suppl 3(Suppl 3):S2. PubMed ID: 19090999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.
    Banks WA
    Adv Drug Deliv Rev; 2012 May; 64(7):629-39. PubMed ID: 22202501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Blood Brain Barrier and its Role in Alzheimer's Therapy: An Overview.
    Jakki SL; Senthil V; Yasam VR; Chandrasekar MJN; Vijayaraghavan C
    Curr Drug Targets; 2018; 19(2):155-169. PubMed ID: 28606049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery.
    Alavijeh MS; Chishty M; Qaiser MZ; Palmer AM
    NeuroRx; 2005 Oct; 2(4):554-71. PubMed ID: 16489365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted drug delivery across the blood brain barrier in Alzheimer's disease.
    Rocha S
    Curr Pharm Des; 2013; 19(37):6635-46. PubMed ID: 23621533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease.
    Roney C; Kulkarni P; Arora V; Antich P; Bonte F; Wu A; Mallikarjuana NN; Manohar S; Liang HF; Kulkarni AR; Sung HW; Sairam M; Aminabhavi TM
    J Control Release; 2005 Nov; 108(2-3):193-214. PubMed ID: 16246446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The blood-brain barrier in Alzheimer's disease: novel therapeutic targets and nanodrug delivery.
    Sharma HS; Castellani RJ; Smith MA; Sharma A
    Int Rev Neurobiol; 2012; 102():47-90. PubMed ID: 22748826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis.
    Tashima T
    Chem Pharm Bull (Tokyo); 2020; 68(4):316-325. PubMed ID: 32238649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Nanoparticles for the Treatment of Alzheimer's Disease.
    Martín-Rapun R; De Matteis L; Ambrosone A; Garcia-Embid S; Gutierrez L; de la Fuente JM
    Curr Pharm Des; 2017; 23(13):1927-1952. PubMed ID: 28025949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
    Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
    Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Direct drug delivery to the brain].
    Chekhonin VP; Zhirkov IuA; Dmitrieva TB
    Vestn Ross Akad Med Nauk; 2006; (8):30-7. PubMed ID: 17002024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Getting into the brain: approaches to enhance brain drug delivery.
    Patel MM; Goyal BR; Bhadada SV; Bhatt JS; Amin AF
    CNS Drugs; 2009; 23(1):35-58. PubMed ID: 19062774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of Current Strategies for Delivering Alzheimer's Disease Drugs across the Blood-Brain Barrier.
    Wong KH; Riaz MK; Xie Y; Zhang X; Liu Q; Chen H; Bian Z; Chen X; Lu A; Yang Z
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational aspects of blood-brain barrier transport and central nervous system effects of drugs: from discovery to patients.
    de Lange EC; Hammarlund-Udenaes M
    Clin Pharmacol Ther; 2015 Apr; 97(4):380-94. PubMed ID: 25670219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.